Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid Molecular Diagnostic Device to Detect and Differentiate Ebola and Marburg Virus Species

By LabMedica International staff writers
Posted on 30 Jul 2025

Outbreaks of high-consequence pathogens such as Ebolavirus and Marburgvirus pose serious threats to global health, especially in remote regions where access to reliable and rapid diagnostics is limited. More...

Traditional centralized diagnostic models are slow and resource-intensive, making them ineffective during emergent health crises. In many cases, timely treatment and containment are hindered by the lack of point-of-care tools that can deliver quick and accurate detection of these viruses. Now, researchers are developing a rapid, portable diagnostic solution capable of detecting and differentiating filoviruses from small blood samples within 30 minutes, supporting timely responses in both field and clinical settings.

Aptitude Medical Systems (Goleta, CA, USA) is advancing the development of the Metrix Filovirus Panel using its next-generation molecular diagnostics platform, Metrix. The Metrix Filovirus Panel is designed as a compact, user-friendly diagnostic device that provides lab-quality performance in decentralized settings. It works with venous or fingerstick blood samples, making it suitable for use even in resource-limited environments. The panel expands the capabilities of the Metrix platform to include blood-based applications for the first time, advancing its utility beyond previously authorized COVID-19 and flu tests.

Aptitude is continuing with the development, validation, and regulatory clearance of the Metrix Filovirus Panel in partnership with the Biomedical Advanced Research and Development Authority (BARDA), which is providing USD 9 million in funding. The company envisions broad deployment of the technology to support early detection and containment of viral outbreaks. By reducing dependence on centralized labs and enabling low-cost, point-of-care molecular diagnostics, the solution empowers healthcare providers and public health systems to respond more effectively.

“The Metrix Filovirus Panel is designed to deliver rapid, reliable results in challenging settings, enabling timely treatment and containment of outbreaks, breaking reliance on traditional centralized models which simply do not scale well in the face of an emergent threat,” said Scott Ferguson, PhD, CEO of Aptitude Medical Systems.

"Point-of-care diagnostics are essential for effectively addressing outbreaks of high-consequence pathogens like Ebolavirus and Marburgvirus species," added JP Wang, PhD, CTO, President, and Executive Chairman of Aptitude. "This collaboration enables the use of blood samples on the Metrix platform, for the first time, significantly expanding the power of the platform to a wide range of applications."

Related Links:
Aptitude Medical Systems


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Automatic Hematology Analyzer
DH-800 Series
New
Silver Member
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.